Advertisement

Topics

Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results

12:11 EDT 29 Aug 2018 | Investing News Network

Cotinga Pharmaceuticals (TSXV:COT) has announced its financial and operating results for Q4 and full year ended April 30, 2018. As quoted in the press release: Advanced the clinical development of COTI-2: In March 2018, Cotinga submitted an updated clinical package to regulatory authorities to expand its ongoing clinical trial of COTI-2. The protocol amendment expanded … Continued

The post Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results appeared first on Investing News Network.

Original Article: Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results

NEXT ARTICLE

More From BioPortfolio on "Cotinga Pharmaceuticals Reports Fiscal 2018 Fourth Quarter and Full Year Financial and Operating Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...